Researchers assessed variations in patterns of care and time to initial treatment for women diagnosed with breast, cervical, or ovarian cancer in various countries.

A phase 2 RCT evaluated progression of prostate-specific antigen and urinary symptoms in men with low-risk prostate cancer who were administered phytochemical-rich food and Lactobacillus probiotic ...

Rates for plans sold through federal Obamacare marketplaces will rise, on average, by 30% next year, according to a new analysis from the health research group KFF. States that run their own ...

The ESC has published a scientific statement regarding heart failure with preserved ejection fraction in patients with cancer and cancer survivors.

The phase 3 ALBAN trial tested atezolizumab plus BCG in BCG-naïve patients with high-risk, non-muscle-invasive bladder cancer (NMIBC).

A cross-sectional study evaluated if the mode of sexual orientation and gender identification disclosure was associated with receiving clinical resources tailored to LGBTQ+ cancer survivors.

(HealthDay News) — The US Food and Drug Administration approved belantamab mafodotin-blmf in combination with bortezomib and dexamethasone for the treatment of adult patients with relapsed or ...

(HealthDay News) — A direct-to-patient digital health intervention increases rates of lung cancer screening, according to a study published online in the Journal of the American Medical Association.

The LITESPARK-022 and LITESPARK-011 trials evaluated combination regimens containing belzutifan in patients with advanced clear cell RCC.

Macrovascular infiltration and spikes in circulating tumor cell clusters are associated with cancer mortality, according to a study.

During the COVID-19 pandemic, Medicaid expansion was associated with smaller declines in early-stage cancer detection.

OptiTROP-Lung04 study showed sac-TMT improved survival in pts with EGFR-mutated NSCLC who had progressed on EGFR-targeted TKIs, compared with chemotherapy.